Trademarkia Logo

Australia

AU$
ONCXERNA
Protected: Registered/protected

Last updated on 23 Mar 2021

Owner Info

ONCXERNA THERAPEUTICS, INC.

300 Fifth Avenue, Suite 6040

Waltham, Massachusetts 02451, UNITED STATES OF AMERICA

Serial Number

2135457 filed on 25 Sept 2020

Correspondent

Monica Riva Talley of Sterne, Kessler, Goldstein & Fox P.L.L.C.

1100 New York Avenue, NW,

Washington DC 20005,

UNITED STATES OF AMERICA

ONCXERNA

Classification Information


Class [001]
Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules, biol Read More

Class [005]
Pharmaceutical preparations, namely, proteins for the treatment and diagnosis of cancer, viral infections and infectious diseases; diagnostic kits con Read More

Class [042]
Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development wi Read More

Mark Details


Serial Number

2135457

Registered On

25 Sept 2020

Renewal On

25 Sept 2030

Mark Type

WORD

Priority Claim (Convention Details)


Date

12 Aug 2020

Mark Type

US

Legal History


Show more

Status DateAction Taken
23rd Mar 2021International Registration in Australia Protected correspondence sent
22nd Mar 2021IP Right Registration Published
22nd Mar 2021Status change to Registered/Protected
21st Jan 2021Amendment to Amend Owner Requested
13th Jan 2021Application Accepted correspondence sent
13th Jan 2021IP Right has been Examined
13th Jan 2021IP Right Acceptance Published
3rd Dec 2020Status change to Accepted
12th Nov 2020Awaiting examination
12th Nov 2020Examination expedited